HK1069600A1 - Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein - Google Patents

Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein

Info

Publication number
HK1069600A1
HK1069600A1 HK05102122.2A HK05102122A HK1069600A1 HK 1069600 A1 HK1069600 A1 HK 1069600A1 HK 05102122 A HK05102122 A HK 05102122A HK 1069600 A1 HK1069600 A1 HK 1069600A1
Authority
HK
Hong Kong
Prior art keywords
determination
detection
reagent
hcv core
core antigens
Prior art date
Application number
HK05102122.2A
Other languages
English (en)
Inventor
Kazuki Morita
Ayako Nishida
Masanori Fukui
Masaru Kondou
Michinori Kohara
Original Assignee
Kyowa Medex Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Medex Co Ltd filed Critical Kyowa Medex Co Ltd
Publication of HK1069600A1 publication Critical patent/HK1069600A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK05102122.2A 1999-08-19 2005-03-11 Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein HK1069600A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23317199 1999-08-19

Publications (1)

Publication Number Publication Date
HK1069600A1 true HK1069600A1 (en) 2005-05-27

Family

ID=16950852

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05102122.2A HK1069600A1 (en) 1999-08-19 2005-03-11 Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein
HK07109572.0A HK1104352A1 (en) 1999-08-19 2007-09-04 Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK07109572.0A HK1104352A1 (en) 1999-08-19 2007-09-04 Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein

Country Status (6)

Country Link
EP (1) EP1083428A3 (xx)
JP (2) JP4931962B2 (xx)
KR (1) KR100730529B1 (xx)
CN (3) CN1144047C (xx)
CA (1) CA2316130A1 (xx)
HK (2) HK1069600A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
US8865398B2 (en) * 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
JP6091158B2 (ja) 2012-10-23 2017-03-08 デンカ生研株式会社 尿を変性剤で前処理することによる免疫測定系の感度を上げる方法
CN103675280B (zh) * 2013-12-17 2015-05-20 山东博科生物产业有限公司 一种检测丙肝核心抗原的标记物及试剂
CN104374915B (zh) * 2014-10-30 2016-06-01 北京大学人民医院 用于检测丙型肝炎病毒的核心抗原片段及其应用
JP7044721B2 (ja) 2016-05-31 2022-03-30 エフ．ホフマン－ラ ロシュ アーゲー Ｈｃｖコア抗原の迅速な検出のための前処理法
CN109154616B (zh) * 2016-05-31 2022-07-12 豪夫迈·罗氏有限公司 用于病毒抗原的血清学检测的方法
CN109696550B (zh) * 2017-10-20 2022-08-26 成都蓝瑙生物技术有限公司 用于脑中风的发光elisa体液样品稳定化用水溶液
CN109696551B (zh) * 2017-10-20 2023-01-17 成都蓝瑙生物技术有限公司 用于脑中风诊断或预后评价的体外检测设备
CN109696549B (zh) * 2017-10-20 2022-11-01 成都蓝瑙生物技术有限公司 用于脑中风的发光elisa体外诊断试剂盒
CN109696552B (zh) * 2017-10-20 2022-10-14 成都蓝瑙生物技术有限公司 用于脑中风的发光elisa体外诊断试剂盒以及体外检测设备
CN109608552A (zh) * 2018-12-26 2019-04-12 杭州亿米诺生物科技有限公司 一种小反刍兽疫重组融合蛋白及其制备方法和应用
CN109738648B (zh) * 2018-12-29 2021-09-17 山东莱博生物科技有限公司 稳定高效表达丙型肝炎病毒核心抗原抗体的工程细胞株及其应用
CN113125756B (zh) * 2020-07-15 2022-10-25 南京岚煜生物科技有限公司 抗体标准品赋值和抗原中和当量确定的方法
CN112730839B (zh) * 2021-01-20 2024-01-30 宁波海尔施智造有限公司 一种磁微粒化学发光法测定细胞角蛋白19片段含量的试剂盒
CN114137203A (zh) * 2021-10-21 2022-03-04 广州万孚生物技术股份有限公司 抗原与碱性磷酸酶结合物的制备方法
CN114544933A (zh) * 2022-02-21 2022-05-27 丹娜(天津)生物科技股份有限公司 一种用于曲霉半乳甘露聚糖检测的样品处理液及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU543007B2 (en) * 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay
US4536478A (en) * 1984-04-05 1985-08-20 Seragan Diagnostics, Inc. Method for reducing non-specific interferences in agglutination immunoassays
GB8607101D0 (en) * 1986-03-21 1986-04-30 Serono Diagnostics Ltd Immunoassay
DE3901458A1 (de) * 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
US5753430A (en) * 1990-11-07 1998-05-19 Abbott Laboratories Monoclonal antibodies to hepatitis C virus and method for using same
DK0556320T3 (da) * 1990-11-07 1999-10-18 Abbott Lab Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
ZA927837B (en) * 1991-10-15 1994-03-11 Akzo Nv Monoclonal antibodiesto hepatitis C virus
GB9204274D0 (en) * 1992-02-28 1992-04-08 Wellcome Found Novel peptides
FR2690921B1 (fr) * 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
WO1994024558A1 (en) * 1993-04-19 1994-10-27 E.I. Du Pont De Nemours And Company A method for improving the signal to noise ratio of an immunoassay
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
CN1044384C (zh) * 1994-08-25 1999-07-28 中国药品生物制品检定所 抗丙型肝炎病毒抗原单克隆抗体细胞株建立及其单克隆抗体
FR2760458B1 (fr) * 1997-03-05 1999-04-23 Bio Merieux Peptide structural antigenique, composes antigenique et immunogene et utilisations dans la detection, la prevention et le traitement d'une infection par le vhc
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc

Also Published As

Publication number Publication date
JP4931963B2 (ja) 2012-05-16
CN1932517B (zh) 2012-05-09
EP1083428A2 (en) 2001-03-14
CN1144047C (zh) 2004-03-31
JP2009197033A (ja) 2009-09-03
KR100730529B1 (ko) 2007-06-20
CA2316130A1 (en) 2001-02-19
CN1285513A (zh) 2001-02-28
EP1083428A3 (en) 2001-05-16
JP2009197034A (ja) 2009-09-03
HK1104352A1 (en) 2008-01-11
KR20010050118A (ko) 2001-06-15
CN100408684C (zh) 2008-08-06
CN1532286A (zh) 2004-09-29
JP4931962B2 (ja) 2012-05-16
CN1932517A (zh) 2007-03-21

Similar Documents

Publication Publication Date Title
HK1069600A1 (en) Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein
GB0409119D0 (en) System and methods for detecting harmful agents within contents of mail
HK1096483A1 (en) Emotion detecting method and system of the same
IL139631A0 (en) Enumeration method of analyte detection
GB0008303D0 (en) Measurement system and method
IL138278A0 (en) Improved urine specimen container and method for using same
EP1329717A4 (en) REAGENTS AND PROCEDURES FOR DETECTING SUBSTANCES
EP1005479A4 (en) RNS INSULATION REAGENT AND METHOD
IL123451A0 (en) Method and kit for the detection of explosives
EP1202060A4 (en) BIOSENSOR AND MANUFACTURING METHOD
IL138955A0 (en) Reaction measurement method and system
GB2365125B (en) Method of and sensor for testing liquids
IL154013A0 (en) Method and system for detecting hidden edges
HK1049025A1 (en) Method of detecting trichothecene mycotoxins and reagent thereof
IL144365A0 (en) Method and system for general purpose analysis of experimental data
HK1040769A1 (en) Method for detection and quantification of specific nucleic acid.
EP1319626A4 (en) ELEVATOR AND METHOD OF INSPECTING THE SAME
AU8561501A (en) System and method for management of specimens
AU2002365084A8 (en) Method and reagent for the detection of proteins and peptides
GB0030360D0 (en) Reagents and methods for use in the detection of analytes
GB9807848D0 (en) Assay method and means
AU2002357252A8 (en) System and method for detecting deception
IL136180A0 (en) Method of detecting prostate specific antigen
GB0010953D0 (en) Method of detection and segmentation of transmissions
GB9804529D0 (en) Method for the detection of antigens or antibodies

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20200817